4//SEC Filing
GALECTIN THERAPEUTICS INC 4
Accession 0000914062-13-000232
$GALTCIK 0001133416operating
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:18 PM ET
Size
7.2 KB
Accession
0000914062-13-000232
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Purchase
Common Stock
2013-10-02$9.97/sh+125$1,246→ 16,369 total - Purchase
Common Stock
2013-10-01$9.96/sh+376$3,746→ 16,244 total
Holdings
- 4,947(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.
- [F2]Reflects weighted average price. Range of prices were between $9.95 and $9.97. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001133416
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 5:18 PM ET
- Size
- 7.2 KB